Metrion Biosciences Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Based in Cambridge, England, Metrion Biosciences operates as a specialist preclinical drug discovery CRO with a core focus on ion channel screening, including high-throughput assays. It also conducts translational cardiac safety studies and neuroscience assays using dorsal root ganglion (DRG) and other primary neurons. Clients value the high-quality data and scientific insight delivered through a collaborative approach that helps interpret results and informs tailored recommendations, effectively extending their research teams. 

The leadership team brings extensive drug discovery experience, with significant emphasis on ion channels and a track record reflected in numerous publications. In 2026, the company expanded its Granta Park facilities in Cambridge, doubling laboratory space to support ongoing and future client projects.

Sign up for free to view info

Company overview Employee directory